Revolutionizing #RareDiseases with #AI at DREAMS: 🔬 Cells, Data, Algorithms ✅ Validating Predictions 💊 Towards Therapy Join us in turning AI breakthroughs into hope! Swipe through to discover more! 👇 Follow @DREAMS Project.

Join us to explore Innovation in Clinical Trials for Rare Diseases with renowned experts! 🗓️ Date: February 28, 2025 🕒 Time: 12:00 PM – 1:30 PM (CET) 🌐 Format: Online (registration: #RareDiseaseDay #RareDiseases #DREAMSProject #webinar

Exciting news! Join us for the DREAMS Webinar on Innovation in Clinical Trials for Rare Diseases. 🗓️ Save the date: Feb 28, 2025 📍 Online event 🌐 Free Registration: #RareDiseaseDay #RareDiseases #DREAMSProject #webinar

As the coordinator of @DreamsPjt_EU, @IStemFrance leads efforts to develop therapies for five rare neuromuscular diseases. With induced pluripotent stem cells, they create disease models, identify targets, and screen drug candidates—while uniting the Dreams consortium.

⏳ 3 days to #Téléthon2024! @lepetitjournal highlights how #AI is transforming rare disease research. Focus on the @IStemFrance lab's role in the DREAMS project—AI-driven Drug Repurposing for Muscular Diseases. 💡Insights from @Xavier_Nissan 📝Jean Bodéré

A year ago, we launched the @DreamsPjt_EU to address the urgent need for treatments for five neuromuscular disorders. With support from @EU_HaDEA and our project partners, we've made significant progress in our research. Learn more in our new brochure 📄.

RT @RareRevolutionM: DREAMS (@DreamsPjt_EU): a year of innovation and progress in the quest for #NeuromuscularDisease therapies. Read at h…

🔗 Learn more about our key advancements in foundational research and the progress of clinical trial development: 📢 Help us spread the word by sharing the #PressRelease:

Proud to highlight the @TechnionLive - Israel Institute of Technology as a key partner in the @DreamsPjt_EU! 🇮🇱 Their research will be crucial for understanding #RareDiseases and paving the way for new therapies. 👉Learn more about our partnership:

RT @ERDERA_org: 🚀 Join us for the ERDERA launch event! 🗓️ 28 Oct 2024 ⏰ 14:00-16:15 CET 💻 Online Don't miss insights from top experts…

🌟 Spotlight on the DREAMS Project at #EuropeanResearchersNight! Thrilled to showcase our AI-driven work on therapies for rare neuromuscular disorders at #ERN2024 in Coimbra! 🔗 More here: #DREAMSHorizonEU #EUScience #RareDiseases

We wish you an inspiring #WorldDreamDay! 🔬At @DreamsPjt_EU, we’re dreaming big: Advancing research on potential therapies for rare neuromuscular diseases. Join us in shaping a hopeful future!✨ 🔗 #TogetherWeDream #DreamsForTheFuture @dayfordreamers

Excited to partner with @UnivdeCoimbra! Founded in 1290, UC leads in education and research. 🔬 🔬 Dr. Lino Ferreira and his team are advancing in vitro tissue models with #iPSCs for #RDs and innovative treatments. 👉 Discover their role here:

Curious about how #AI is transforming drug discovery? @Kantify, co-leading @DreamsPjt_EU with @IStemFrance, is leveraging its AI expertise to discover treatments for neuromuscular disorders and enhance efficiency. Check out @Segozone's insights 📽️:

RT @kantify: AI is a **key** technology to accelerate rare disease drug discovery. Discover how we contribution to the EU funded DREAMS p…

🤝 Meet #TheDREAMSTeam: @kantify, led by CEO @Segozone. This Belgian TechBio uses AI for #DrugDiscovery, focusing on rare diseases and cancer. As co-coordinator of the @DreamsPjt_EU, Kantify targets 5 #NMDs with advanced AI. 🎦 📰

RT @Science_Open: 'DREAMS - Drug REpurposing with Artificial intelligence for Muscular disorderS' by Xavier Nissan @DreamsPjt_EU a #RExPO24…

We extend our heartfelt thanks to @REPO4EU for organizing #RExPO24 event and for the opportunity to engage in discussions that will drive significant advancements in the treatment of #RareDiseases. 🤝